세계의 맵핑 카테터 시장 : 규모, 점유율, 동향 분석(기술별, 적응증별, 최종 용도별, 지역별), 부문별 예측(2025-2030년)

Mapping Catheters Market Growth & Trends:

The global mapping catheters market size is expected to reach USD 4.96 billion by 2030, registering a CAGR of 8.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The primary factors driving the market are the rising cases of CVD, increasing arrhythmia (AF) incidence, technological advancements, and government initiatives. According to the (HRS) Heart Rhythm Society article published in August 2023, Atrial fibrillation (AFib) affects nearly 40 million individuals globally, including 6 million in the United States, making it the most prevalent cardiac arrhythmia. Almost one in four adults over 40 face the risk of developing AFib, often without recognizing early symptoms; the demand for timely and accurate diagnosis is skyrocketing. This rising need fuels the market, as these tools are essential for pinpointing arrhythmic sites and guiding targeted treatment, ultimately improving patient outcomes and reducing the risk of serious complications like stroke and heart failure.

Technological advancements in mapping systems are driving market growth. For instance, in June 2024, New tools like multielectrode basket catheters and devices capable of mapping cardiac arteries and epicardial veins enable detailed three-dimensional visualization of cardiac activation sequences, even during vacuum therapy. Additionally, computerized non-contact mapping systems transform electrophysiology by leveraging algorithms to reconstruct electrograms and create 3D isopotential maps without direct contact with the endocardial surface. These technological strides are complemented by remote monitoring and infection control improvements, which allow continuous heart rhythm assessment outside of hospital environments-enhancing patient safety, enabling timely therapeutic interventions, and minimizing risks associated with invasive procedures.

Moreover, the rising strategic initiatives by the market players fuel market growth. For instance, in May 2024, Biosense Webster, a Johnson & Johnson MedTech company and a global leader in treating cardiac arrhythmias, introduced CARTO 3 System Version 8, an advanced iteration of its 3D cardiac mapping platform. This upgrade enhances precision and procedural efficiency during catheter ablation treatments for arrhythmias like atrial fibrillation. Among the latest additions are the CARTO ELEVATE(TM) and CARTOSOUND(TM) FAM Modules, both developed to support electrophysiologists with improved accuracy, consistency, and workflow during complex ablation procedures.

Mapping Catheters Market Report Highlights:

• The High-Density (HD) mapping segment held the largest share of over 49.3% in 2024. The increasing incidence of AF and technological advancement drives the segment growth. High-Density (HD) Mapping is a technique that captures detailed electrical signals from the heart for precise arrhythmia diagnosis and treatment
• The Atrial Fibrillation (AF) segment held the largest share, over 66.8%, in 2024 due to the increasing incidence of AF, growing initiatives by key players, and technological advancements
• The hospital segment held the largest share at 36.8% in 2024. Hospitals increasingly perform catheter procedures, reflecting the growing demand for advanced electrophysiological interventions
• North America dominated the market, with a share of 40.4% in 2024, owing to the increasing prevalence of cardiac arrhythmia, including increasing cardiac procedures and technological advancements
• Market players operating in the market include Abbott Laboratories, Acutus Medical, Inc., Johnson & Johnson, Medtronic, Boston Scientific Corporation, Microport Scientific Corporation, Lepu Medical, Stereotaxis, Inc., and Koninklijke Philips N.V.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Technology
  • 1.2.2. Indication
  • 1.2.3. End-use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecast timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity price analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Technology Segment
  • 2.2.2. Indication Segment
  • 2.2.3. End-use Segment
  • 2.2.4. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Global Mapping Catheters Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of cardiac arrhythmias
    • 3.2.1.2. Increased cardiac procedures
    • 3.2.1.3. Technological advancements
    • 3.2.1.4. Growing awareness of early detection of AF
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost associated with the devices and procedures
    • 3.2.2.2. Regulatory compliance
• 3.3. Mapping Catheters Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Mapping Catheters Market: Technology Estimates & Trend Analysis

• 4.1. Mapping Catheters Market: Technology Dashboard
• 4.2. Mapping Catheters Market: Technology Movement Analysis
• 4.3. Mapping Catheters Market Size & Forecasts and Trend Analysis, by Technology, 2018 - 2030 (USD Million)
• 4.4. High-Density (HD) Mapping
  • 4.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 4.5. Contact Force Sensing
  • 4.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 4.6. Others
  • 4.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. Mapping Catheters Market: Indication Estimates & Trend Analysis

• 5.1. Mapping Catheters Market: Indication Dashboard
• 5.2. Mapping Catheters Market: Indication Movement Analysis
• 5.3. Mapping Catheters Market Size & Forecasts and Trend Analysis, by Indication, 2018 - 2030 (USD Million)
• 5.4. Atrial Fibrillation (AF)
  • 5.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 5.5. Atrial Flutter (AFL)
  • 5.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 5.6. Ventricular Tachycardia (VT)
  • 5.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Mapping Catheters Market: End-use Estimates & Trend Analysis

• 6.1. Mapping Catheters Market: End-use Dashboard
• 6.2. Mapping Catheters Market: End-use Movement Analysis
• 6.3. Mapping Catheters Market Size & Forecasts and Trend Analysis, by End-use, 2018 - 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 6.5. Ambulatory Surgical Centers
  • 6.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Mapping Catheters Market: Regional Estimates & Trend Analysis by Country, Technology, Indication, & End-use

• 7.1. Global Mapping Catheters Market: Regional Dashboard
• 7.2. Market Size & Forecasts Trend Analysis, 2018 - 2030
• 7.3. North America
  • 7.3.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Regulatory framework/ reimbursement structure
    • 7.3.4.3. Competitive scenario
    • 7.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.8. Norway
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.9. Denmark
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Regulatory framework/ reimbursement structure
    • 7.4.9.3. Competitive scenario
    • 7.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.3. Japan
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.5. Australia
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.7. South Korea
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework/ reimbursement structure
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.3. South Africa
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework/ reimbursement structure
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2024
  • 8.3.4. Abbott Laboratories
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Acutus Medical, Inc.
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Johnson & Johnson
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Medtronic
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Boston Scientific Corporation
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Microport Scientific Corporation
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Lepu Medical
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Stereotaxis, Inc.
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Koninklijke Philips N.V.
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives